February 2018, a collaboration agreement was signed between AxxessBio and myTomorrows to create awareness on the availability of non-registered products in Asia under the Early Access Programs, e.g., Named Patient Importation, as per local regulations, and for myTomorrows’s search engine for unregistered medicinal products.
The partnership between AxxessBio and myTomorrows allows healthcare providers and patients in Asia to (potentially) have access to pre-registered medicines under these special programs.
myTomorrows is an international platform that links patients facing unmet medical needs to treatments in development worldwide. It bridges the gap between patients and their healthcare providers who are searching for treatment options and the pharmaceutical companies who provide them.
For more information on the company and its services please visit https://mytomorrows.com/en
